Innovative In Vitro Chemo-Hormonal Drug Therapy for Refractory Thyroid Carcinomas

More than 95% of the thyroid carcinomas are well differentiated types showing favorable prognosis. However, only a few therapeutic options are available to treat the patients with undifferentiated thyroid carcinomas, especially with refractory thyroid carcinomas that are not amenable to surgery or r...

Descripción completa

Detalles Bibliográficos
Autores principales: Sung, Tae-Yon, Choi, Sung Ho, Lee, Jung Min, Jeong, Jong Ju, Kang, Sang-Wook, Chung, Woong Youn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390719/
https://www.ncbi.nlm.nih.gov/pubmed/22787366
http://dx.doi.org/10.3346/jkms.2012.27.7.729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390719/
https://www.ncbi.nlm.nih.gov/pubmed/22787366
http://dx.doi.org/10.3346/jkms.2012.27.7.729

Ejemplares similares